Streetbeat News

MRMD

MariMed Inc

Employees

326

Industry

Medicinal and Botanical Manufacturing

Open

0.16

Mkt cap

59M

Volume

18K

High

0.16

P/E Ratio

-5.17

52-wk high

0.39

Low

0.15

Div yield

N/A

52-wk low

0.14

Cannabis stocks experienced significant movements on January 24, 2024. Notable gainers included Global Hemp Group, Target Group, and Item 9 Labs, with increases of 68.40%, 47.06%, and 14.29% respectively. Trulieve Cannabis and MJ Holdings also saw gains over 11%. Corbus Pharmaceuticals and Neptune Wellness Solutions were among the NASDAQ-listed gainers. Conversely, MedMen Enterprises and EVIO suffered dramatic losses, closing down 99.99% and 98.00%. Other notable losers included Khiron Life Sciences and Cara Therapeutics. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 9:30 pm

US cannabis stocks have surged by 69% following hints from the HHS about potential reclassification of marijuana. Ascend Wellness (AAWH) led with a 25.44% increase, while MariMed (MRMD) and Gold Flora (GRAM) also saw significant gains. The Cannabist (CBSTF) experienced a slight decline. The HHS's unredacted document recommended reclassifying cannabis to Schedule III, which has sparked media attention and discussions on platforms like Reddit, particularly for Tilray (TLRY). The report suggests political progress on cannabis reform could further boost the industry, which currently has low institutional ownership.

Portfolio Pulse from Nicolás Jose Rodriguez

January 24, 2024 | 6:12 pm

Pablo Zuanic's Q4 2023 cannabis sector report highlights state-specific market trends, with Connecticut, Ohio, Illinois, Maryland, and Rhode Island showing growth. Companies like MariMed, Verano, and Green Thumb Industries benefit from diversified state exposure. The report discusses MSO performance variations, regulatory developments, and potential political shifts that could impact the market. Key players in various states are analyzed, with the DEA's response to cannabis rescheduling being a significant upcoming event.

Portfolio Pulse from Nicolás Jose Rodriguez

January 23, 2024 | 8:38 pm

On January 22, 2024, several cannabis-related stocks experienced significant price movements. Notable gainers included Cansortium, Global Hemp Group, and Blueberries Medical, with increases of 27.27%, 25.00%, and 18.18% respectively. Urban-gro, OrganiGram Holdings, and Psychemedics also saw gains on NASDAQ. Conversely, AusCann Group Holdings, EVIO, and Maple Leaf Green World were among the biggest losers, with AusCann's shares plummeting by 59.42%. Corbus Pharmaceuticals and Eastside Distilling also experienced declines on NASDAQ.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 19, 2024. EVIO led the gainers with a 9900.00% increase, while Rocky Mountain High topped the losers with a 21.62% decline. Notable gainers included Genetic Technologies, OrganiGram Holdings, and Cara Therapeutics, with increases of 42.16%, 10.72%, and 4.80% respectively. Among the losers, Corbus Pharmaceuticals and Greenlane Holdings saw declines of 4.91% and 3.32%.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 9:30 pm

The cannabis sector experienced bearish sentiment on January 18, 2024, with a mix of gainers and losers. Notable gainers included Genetic Technologies (GENE) and Urban-gro (UGRO), while significant losers were Aurora Cannabis (ACB), GrowGeneration (GRWG), OrganiGram Holdings (OGI), Tilray Brands (TLRY), Neptune Wellness Solutions (NEPT), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP), and Village Farms International (VFF).

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:30 pm

Marijuana stocks saw significant movement on January 15, 2024, with Khiron Life Sciences leading the gainers with a 152.73% increase, while MedMen Enterprises experienced a steep decline of 95.71%. Other notable gainers include Global Compliance, CordovaCann, and RIV Capital. The losers' list was topped by AusCann Group Holdings with a 58.82% drop, followed by EnWave and Auxly Cannabis Group.

Portfolio Pulse from Benzinga Insights

January 15, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 12, 2024. Khiron Life Sciences led the gainers with a 152.73% increase, while MedMen Enterprises saw a dramatic 95.71% drop. Other notable gainers include Global Compliance and CordovaCann. Among the losers, AusCann Group Holdings also faced a steep decline. The volatility in these stocks reflects ongoing developments in the cannabis industry.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 9:30 pm

On January 11, 2024, several cannabis stocks experienced significant movements. Notable gainers included Heritage Cannabis Holding, Blueberries Medical, OrganiGram Holdings, and others, with increases ranging from 3.12% to 26.58%. Conversely, several companies faced declines, with Global Compliance leading the losers, followed by Rocky Mountain High, CLS Holdings USA, and others, with decreases ranging from 3.07% to 16.57%. The article lists the closing prices and percentage changes for each mentioned company.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 9:30 pm

Connecticut, Maryland, and Maine have seen booming cannabis markets, with record sales in December 2023 for Connecticut ($27.5 million) and significant annual sales for Maryland ($700 million) and Maine ($200 million). Companies like Ascend Wellness Holdings, iAnthus Capital Holdings, and others are experiencing revenue growth. Maryland's market is particularly strong post-legalization, with $270 million in Q3 2023 sales. Investors are advised to watch for market saturation in Maine and potential challenges in Connecticut, such as limited testing lab capacity.

Portfolio Pulse from Nicolás Jose Rodriguez

January 11, 2024 | 8:47 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.